Hepatocellular Carcinoma Sorafenib: Tumor Volume as a predictive Value for the Response to Therapies?

被引：0
|
作者：
Rukavina, Marion
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2014年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma
    Song, Shaoming
    Bai, Mingzhen
    Li, Xiaofei
    Gong, Shiyi
    Yang, Wenwen
    Lei, Caining
    Tian, Hongwei
    Si, Moubo
    Hao, Xiangyong
    Guo, Tiankang
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (03) : 361 - 378
  • [2] PREDICTIVE FACTORS OF RESPONSE TO SORAFENIB IN HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE PILOT STUDY
    Castain, C.
    Blanc, J. -F.
    Bioulac-Sage, P.
    Diallo, A.
    Chevet, E.
    Possenti, L.
    Trillaud, H.
    Le-Bail, B.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S390 - S390
  • [3] FACTORS PREDICTIVE FOR TUMOR CONTROL AMONG HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB
    Tortora, R.
    Lanza, A. Galeota
    Lampasi, F.
    De Luca, M.
    Tartaglione, M. T.
    Pacilio, R.
    Di Costanzo, G. G.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S266 - S266
  • [4] PREDICTIVE FACTORS FOR TUMOR CONTROL AMONG HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB
    Tortora, R.
    Lanza, A. Galeota
    Lampasi, F.
    De Luca, M.
    Tartaglione, M. T.
    Pacilio, R.
    Di Costanzo, G. G.
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 : S148 - S148
  • [5] Sorafenib in hepatocellular carcinoma:efficacy and predictive factors
    Li Jing
    [J]. Military Medical Research, 2011, (06) : 324 - 334
  • [6] Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward?
    Bargellini, Irene
    Scionti, Alessandra
    Mismas, Valeria
    Masi, Gianluca
    Vivaldi, Caterina
    Bartolozzi, Carlo
    Sacco, Rodolfo
    [J]. ONCOLOGY, 2014, 86 (04) : 191 - 198
  • [7] Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma
    Kostek, Osman
    Yilmaz, Erdem
    Hacioglu, Muhammet Bekir
    Erdogan, Bulent
    Kodaz, Hilmi
    Bekmez, Esma Turkmen
    Hacibekiroglu, Ilhan
    Uzunoglu, Sernaz
    Tuncbilek, Nermin
    Cicin, Irfan
    [J]. JOURNAL OF BUON, 2018, 23 (04): : 979 - 984
  • [8] Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma
    Dong, Renshun
    Wang, Tianci
    Dong, Wei
    Zhu, He
    Liu, Qiumeng
    Liang, Huifang
    Chen, Xiaoping
    Zhang, Bixiang
    Zhang, Xuewu
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [9] Predictive Value of Tumor Volume on Local Control in Hepatocellular Carcinoma Treated with Image Guided Hypofractionated Radiation Treatment
    Kumar, R.
    Neibart, S. S.
    Kim, J.
    Mamidanna, S.
    Deek, M. P.
    Jabbour, S. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E310 - E310
  • [10] PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma
    Wang, Pusen
    Jiang, Zhongyi
    Liu, Xueni
    Yu, Kanru
    Wang, Chunguang
    Li, Hao
    Zhong, Lin
    [J]. CANCER MEDICINE, 2020, 9 (19): : 6972 - 6983
12345